Home » Advanced Oncotherapy (AVO) » Advanced Oncotherapy (AVO) – Updated major shareholder list to include Bracknor Investment Group

Advanced Oncotherapy (AVO) – Updated major shareholder list to include Bracknor Investment Group

Advanced Oncotherapy (AVO) – Major Shareholders

Shares in issue: 72,467,783

Major Shareholders Information
Shareholder Number of Shares % of Total In Issue
Brahma AG 10,850,491 15.0%
Mr Michael Stephen Bradfield 7,080,740 9.8%
MK Trust Co., LTD 4,850,000 6.7%
Michael Sinclair & Family 4,628,229 6.4%
Banca Profilo SPA 3,750,000 5.2%
Hargreaves Lansdown Asset  Mgt 3,592,410 5.0%
AB Segulah 3,369,451 4.6%
Aviva Investors 3,212,036 4.4%
Dr P N Plowman 2,636,799 3.6%
Pi-Capital LLC 2,000,000 2.8%
Barclays Wealth and Investment  Management (UK) 1,671,916 2.3%
Credit Suisse (Italy) SPA 1,575,000 2.2%
Michael Peter Stephen Horgan 1,502,563 2.1%
Halifax Share Dealing 1,485,378 2.0%
TD Direct Investing 1,243,975 1.7%
Alliance Trust Savings 1,032,307 1.4%
Walker Crips Wealth Mgt.Ltd 1,026,969 1.4%
Fundsdirect 963,146 1.3%
Mijesi AB 950,143 1.3%
Selftrade – Talos Securities 949,047 1.3%
Bracknor Investment Group(1) 829,410 1.1%
Dr Enrico C Vanni 823,946 1.1%
Bestinvest 805,591 1.1%
Interactive Investor Sharedealing 733,541 1.0%
Other holdings, below 1% 11,734,105 16.2%
Total In Issue 72,467,783 100%

 

Director’s Information
Shareholder Number of Shares % of Total In Issue
Holdings by Directors or Holdings Under Their Control
Michael Bradfield 7,080,740 9.8%
Dr Michael Sinclair & Family 4,628,229 6.4%
Dr Enrico C Vanni 823,946 1.1%
Nicolas Serandour 93,800 0.1%
Mr Sanjeev Pandya 58,616 0.1%
Prof Steve Myers 50,569 0.1%
Prof Chris Nutting 14,816 0.0%
Hans von Celsing 0 0.0%
12,750,716 17.6%

(1) Advanced Oncotherapy plc has been informed by Bracknor Investment Group that as of March 14th 2017 they have increased their stake in the company by buying shares on the open market.

This information was last updated on 30 January 2017.

Share price data provided by vwd group & financial data provided by Morningstar.

Link here to view on the Advanced Oncotherapy website.

 


Leave a comment

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.